Skip to main content
SpringerLink
Log in
Book cover

Target Volume Delineation and Treatment Planning for Particle Therapy pp 289–302Cite as

Gynecologic malignancies

  • Chapter
  • First Online:

  • 1623 Accesses

Part of the book series: Practical Guides in Radiation Oncology ((PGRO))

This is a preview of subscription content, log in via an institution.

References

  1. Siegel RL, et al. Cancer Statistics, 2016. CA Cancer J Clin. 2016;66:7–30.

    Article  PubMed  Google Scholar 

  2. Sedlis A, et al. A randomized trial of pelvic radiation therapy versus no further therapy in selected patients with stage IB carcinoma of the cervix after radical hysterectomy and pelvic lymphadenectomy: a Gynecologic Oncology Group Study. Gynecol Oncol. 1999;73(2):177–83.

    Article  CAS  PubMed  Google Scholar 

  3. Rotman M, et al. A phase III randomized trial of postoperative pelvic irradiation in stage IB cervical carcinoma with poor prognostic features: follow-up of a gynecologic oncology group study. Int J Radiat Oncol Biol Phys. 2006;65(1):169–76.

    Article  PubMed  Google Scholar 

  4. Peters WA III, et al. Concurrent chemotherapy and pelvic radiation therapy compared with pelvic radiation therapy alone as adjuvant therapy after radical surgery in high-risk early-stage cancer of the cervix. J Clin Oncol. 2000;18(8):1606–13.

    Article  CAS  PubMed  Google Scholar 

  5. Keys HM, et al. A phase III trial of surgery with or without adjunctive external pelvic radiation therapy in intermediate risk endometrial adenocarcinoma: a Gynecologic Oncology Group study. Gynecol Oncol. 2004;92(3):744–51.

    Article  PubMed  Google Scholar 

  6. Scholten AN, et al. Postoperative radiotherapy for stage 1 endometrial carcinoma: long-term outcome of the randomized PORTEC trial with central pathology review. Int J Radiat Oncol Biol Phys. 2005;63(3):834–8.

    Article  PubMed  Google Scholar 

  7. Sorbe B, et al. External pelvic and vaginal irradiation versus vaginal irradiation alone as postoperative therapy in medium-risk endometrial carcinoma–a prospective randomized study. Int J Radiat Oncol Biol Phys. 2012;82(3):1249–55.

    Article  PubMed  Google Scholar 

  8. Rose PG, et al. Concurrent cisplatin-based radiotherapy and chemotherapy for locally advanced cervical cancer. N Engl J Med. 1999;340:1144–53.

    Article  CAS  PubMed  Google Scholar 

  9. Greven K, et al. Final analysis of RTOG 9708: adjuvant postoperative irradiation combined with cisplatin/paclitaxel chemotherapy following surgery for patients with high-risk endometrial cancer. Gynecol Oncol. 2006;103(1):155–9.

    Article  CAS  PubMed  Google Scholar 

  10. Mauch P, et al. Hematopoietic stem cell compartment: acute and late effects of radiation therapy and chemotherapy. Int J Radiat Oncol Biol Phys. 1995;31(5):1319–39.

    Article  CAS  PubMed  Google Scholar 

  11. Parker K, et al. Five years' experience treating locally advanced cervical cancer with concurrent chemoradiotherapy and high-dose-rate brachytherapy: results from a single institution. Int J Radiat Oncol Biol Phys. 2009;74(1):140–6.

    Article  PubMed  Google Scholar 

  12. Mell LK, et al. Dosimetric predictors of acute hematologic toxicity in cervical cancer patients treated with concurrent cisplatin and intensity-modulated pelvic radiotherapy. Int J Radiat Oncol Biol Phys. 2006;66(5):1356–65.

    Article  PubMed  Google Scholar 

  13. Albuquerque K, et al. Radiation-related predictors of hematologic toxicity after concurrent chemoradiation for cervical cancer and implications for bone marrow-sparing pelvic IMRT. Int J Radiat Oncol Biol Phys. 2011;79(4):1043–7.

    Article  PubMed  Google Scholar 

  14. Klopp AH, et al. Hematologic toxicity in RTOG 0418: a phase 2 study of postoperative IMRT for gynecologic cancer. Int J Radiat Oncol Biol Phys. 2013;86(1):83–90.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  15. Portelance L, et al. Intensity-modulated radiation therapy (IMRT) reduces small bowel, rectum, and bladder doses in patients with cervical cancer receiving pelvic and para-aortic irradiation. Int J Radiat Oncol Biol Phys. 2001;51(1):261–6.

    Article  CAS  PubMed  Google Scholar 

  16. Song WY, et al. Dosimetric comparison study between intensity modulated radiation therapy and three-dimensional conformal proton therapy for pelvic bone marrow sparing in the treatment of cervical cancer. J Appl Clin Med Phys. 2010;11(4):3255.

    Article  PubMed  Google Scholar 

  17. Lin A, et al. Intensity-modulated radiation therapy for the treatment of anal cancer. Clin Colorectal Cancer. 2007;6(10):716–9.

    Article  PubMed  Google Scholar 

  18. Jhingran A, et al. A phase ii study of intensity modulated radiation therapy to the pelvis for postoperative patients with endometrial carcinoma: Radiation Therapy Oncology Group trial 0418. Int J Radiat Oncol Biol Phys. 2012;84(1):e23–8.

    Article  PubMed  Google Scholar 

  19. Milby AB, et al. Dosimetric comparison of combined intensity-modulated radiotherapy (IMRT) and proton therapy versus IMRT alone for pelvic and para-aortic radiotherapy in gynecologic malignancies. Int J Radiat Oncol Biol Phys. 2012;82(3):e477–84.

    Article  PubMed  Google Scholar 

  20. Lin L, et al. Initial report of pencil beam scanning proton therapy for posthysterectomy patients with gynecologic cancer. Int J Radiat Oncol Biol Phys. 2016;95(1):181–9.

    Article  PubMed  Google Scholar 

  21. Tsai C, et al. A prospective randomized trial to study the impact of pretreatment FDG-PET for cervical cancer patients with MRI-detected positive pelvic but negative para-aortic lymphadenopathy. Int J Radiat Oncol Biol Phys. 2010;76(2):477–84.

    Article  PubMed  Google Scholar 

  22. Kidd EA, et al. Clinical outcomes of definitive intensity-modulated radiation therapy with fluorodeoxyglucose-positron emission tomography simulation in patients with locally advanced cervical cancer. Int J Radiat Oncol Biol Phys. 2010;77(4):1085–91.

    Article  PubMed  Google Scholar 

  23. Kidd EA, et al. Lymph node staging by positron emission tomography in cervical cancer: relationship to prognosis. J Clin Oncol. 2010;28(12):2108–13.

    Article  PubMed  Google Scholar 

  24. Simcock B, et al. The role of positron emission tomography/computed tomography in planning radiotherapy in endometrial cancer. Int J Gynecol Cancer. 2015;25(4):645–9.

    Article  PubMed  Google Scholar 

  25. Viswanathan AN, et al. Computed tomography versus magnetic resonance imaging-based contouring in cervical cancer brachytherapy: results of a prospective trial and preliminary guidelines for standardized contours. Int J Gynecol Cancer. 2007;68(2):491–8.

    Google Scholar 

  26. Haie-Meder C, et al. Recommendations from gynaecological (GYN) GEC-ESTRO working group (I): concepts and terms in 3D image based 3D treatment planning in cervix cancer brachytherapy with emphasis on MRI assessment of GTV and CTV. Radiother Oncol. 2005;74(3):235–45.

    Article  PubMed  Google Scholar 

  27. Dimopoulos JCA, et al. Recommendations from gynaecological (GYN) GEC-ESTRO working group (IV): basic principles and parameters for MR imaging within the frame of image based adaptive cervix cancer brachytherapy. Radiother Oncol. 2012;103(1):113–22.

    Article  PubMed  PubMed Central  Google Scholar 

  28. Viswanathan AN, et al. Comparison and consensus guidelines for delineation of clinical target volume for CT- and MR-based brachytherapy in locally advanced cervical cancer. Int J Radiat Oncol Biol Phys. 2014;90(2):320–8.

    Article  PubMed  PubMed Central  Google Scholar 

  29. Harris EE, et al. Assessment of organ motion in postoperative endometrial and cervical cancer patients treated with intensity-modulated radiation therapy. Int J Radiat Oncol Biol Phys. 2011;81(4):e645–50.

    Article  PubMed  Google Scholar 

  30. Jhingran A, et al. Vaginal motion and bladder and rectal volumes during pelvic intensity-modulated radiation therapy after hysterectomy. Int J Radiat Oncol Biol Phys. 2012;82(1):256–62.

    Article  PubMed  Google Scholar 

  31. Ma DJ, et al. Magnitude of interfractional vaginal cuff movement, implications for external irradiation. Int J Radiat Oncol Biol Phys. 2012;82(4):1439–44.

    Article  PubMed  Google Scholar 

  32. Small W Jr, et al. Consensus guidelines for delineation of clinical target volume for intensity-modulated pelvic radiotherapy in postoperative treatment of endometrial and cervical cancer. Int J Radiat Oncol Biol Phys. 2008;71(2):428–34.

    Article  PubMed  Google Scholar 

  33. Lim K, et al. Consensus guidelines for delineation of clinical target volume for intensity-modulated pelvic radiotherapy for the definitive treatment of cervical cancer. Int J Radiat Oncol Biol Phys. 2011;79(2):348–55.

    Article  PubMed  Google Scholar 

  34. Taylor A, et al. Mapping pelvic lymph nodes: guidelines for delineation in intensity-modulated radiotherapy. Int J Radiat Oncol Biol Phys. 2005;63(5):1604–12.

    Article  PubMed  Google Scholar 

  35. Kabolizadeh P, et al. Are radiation therapy oncology group para-aortic contouring guidelines for pancreatic neoplasm applicable to other malignancies - assessment of nodal distribution in gynecological malignancies. Int J Radiat Oncol Biol Phys. 2013;87(1):106–10.

    Article  PubMed  Google Scholar 

  36. NCT01600040, Proton Beam Teletherapy for Post-Hysterectomy Cancers of the Uterus and Cervix; 2012 May 14. Available from: https://clinicaltrials.gov/ct2/show/record/NCT01600040.

  37. Yang M, et al. Theoretical variance analysis of single- and dual-energy computed tomography methods for calculating proton stopping power ratios of biological tissues. Phys Med Biol. 2010;55(5):1343–62.

    Article  CAS  PubMed  Google Scholar 

  38. Hunemohr N, et al. Experimental verification of ion stopping power prediction from dual energy CT data in tissue surrogates. Phys Med Biol. 2013;59(1):83–96.

    Article  PubMed  Google Scholar 

  39. Hansen DC, et al. A simulation study on proton computed tomography (CT) stopping power accuracy using dual energy CT scans as benchmark. Acta Oncol. 2015;54(9):1–5.

    Article  Google Scholar 

  40. Hansen DC, et al. Fast reconstruction of low dose proton CT by sinogram interpolation. Phys Med Biol. 2016;61(15):5868–82.

    Article  PubMed  Google Scholar 

  41. Kurosawa S, et al. Prompt gamma detection for range verification in proton therapy. Curr Appl Phys. 2012;12(2):364–8.

    Article  Google Scholar 

  42. Polf JC, et al. Detecting prompt gamma emission during proton therapy: the effects of detector size and distance from the patient. Phys Med Biol. 2014;59(9):2325–40.

    Article  PubMed  PubMed Central  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. University of Texas-MD Anderson Cancer Center, 1515 Holcombe Blvd Unit 1422, Houston, TX, 77030, USA

    Lilie Lin

  2. Department of Radiation Oncology, University of California, San Francisco, USA

    Jessica E. Scholey

  3. Department of Radiation Oncology, University of Pennsylvania, Philadelphia, PA, USA

    Pamela J. Boimel & Maura Kirk

Authors
  1. Jessica E. Scholey
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Pamela J. Boimel
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Maura Kirk
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Lilie Lin
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Lilie Lin .

Editor information

Editors and Affiliations

  1. Department of Radiation Oncology, Memorial Sloan-Kettering Cancer Center, New York, New York, USA

    Nancy Y. Lee

  2. Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, USA

    Jonathan E. Leeman

  3. Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, USA

    Oren Cahlon

  4. Department of Medical Dosimetry, ProCure Proton Therapy Center, Somerset, New Jersey, USA

    Kevin Sine

  5. Department of Radiation Oncology, Shanghai Proton and Heavy Ion Center, Shanghai, China

    Guoliang Jiang

  6. Department of Radiation Oncology, Shanghai Proton and Heavy Ion Center, Shanghai, China

    Jiade J. Lu

  7. Department of Radiation Oncology, University Medical Center Groningen, Groningen, The Netherlands

    Stefan Both

Rights and permissions

Reprints and permissions

Copyright information

© 2018 Springer International Publishing Switzerland

About this chapter

Cite this chapter

Scholey, J.E., Boimel, P.J., Kirk, M., Lin, L. (2018). Gynecologic malignancies. In: Lee, N., et al. Target Volume Delineation and Treatment Planning for Particle Therapy. Practical Guides in Radiation Oncology. Springer, Cham. https://doi.org/10.1007/978-3-319-42478-1_18

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-42478-1_18

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-42477-4

  • Online ISBN: 978-3-319-42478-1

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation